000756 新华制药
已收盘 11-12 15:00:00
资讯
新帖
简况
股市必读：新华制药新发布《第十一届董事会2026年第三次临时会议决议公告》
证券之星 · 02:53
股市必读：新华制药新发布《第十一届董事会2026年第三次临时会议决议公告》
新华制药董事长贺同庆辞职；拜耳卒中新药在美国获批上市｜医药早参
每日经济新闻 · 11-11 07:00
新华制药董事长贺同庆辞职；拜耳卒中新药在美国获批上市｜医药早参
股市必读：新华制药新发布《第十一届董事会2026年第三次临时会议决议公告》
证券之星 · 11-11 02:45
股市必读：新华制药新发布《第十一届董事会2026年第三次临时会议决议公告》
新华制药董事长由贺同庆变为刘伟民
北京商报 · 11-10 19:24
新华制药董事长由贺同庆变为刘伟民
股市必读：新华制药新发布《关于获得酮咯酸氨丁三醇注射液药品注册证书的公告》
证券之星 · 11-09
股市必读：新华制药新发布《关于获得酮咯酸氨丁三醇注射液药品注册证书的公告》
新华制药最新公告：获得酮咯酸氨丁三醇注射液药品注册证书
证券之星 · 11-06
新华制药最新公告：获得酮咯酸氨丁三醇注射液药品注册证书
新华制药（000756）2026年三季报简析：净利润同比下降23.88%
证券之星 · 10-31
新华制药（000756）2026年三季报简析：净利润同比下降23.88%
图解新华制药三季报：第三季度单季净利润同比增长41.43%
证券之星 · 10-29
图解新华制药三季报：第三季度单季净利润同比增长41.43%
新华制药董事会审议通过2026年第三季度报告
同花顺 · 10-28
新华制药董事会审议通过2026年第三季度报告
股市必读：新华制药新发布《关于尼莫地平片通过仿制药一致性评价的公告》
证券之星 · 10-21
股市必读：新华制药新发布《关于尼莫地平片通过仿制药一致性评价的公告》
新华制药（000756）10月19日主力资金净卖出2088.83万元
证券之星 · 10-20
新华制药（000756）10月19日主力资金净卖出2088.83万元
新华制药：尼莫地平片通过仿制药一致性评价
南方财经网 · 10-19
新华制药：尼莫地平片通过仿制药一致性评价
股市必读：新华制药新发布《关于召开2026年第一次临时股东会的通知》
证券之星 · 10-19
股市必读：新华制药新发布《关于召开2026年第一次临时股东会的通知》
新华制药：关于召开2026年第一次临时股东会的通知
同花顺 · 10-16
新华制药：关于召开2026年第一次临时股东会的通知
新华制药（000756）10月15日主力资金净卖出172.58万元
证券之星 · 10-16
新华制药（000756）10月15日主力资金净卖出172.58万元
股市必读：新华制药新发布《关于高级管理人员减持股份的预披露公告》
证券之星 · 10-15
股市必读：新华制药新发布《关于高级管理人员减持股份的预披露公告》
新华制药（000756）披露高级管理人员减持股份预披露公告，10月13日股价下跌1.0%
证券之星 · 10-13
新华制药（000756）披露高级管理人员减持股份预披露公告，10月13日股价下跌1.0%
10月13日增减持汇总：新华制药等10股拟减持，当日暂无A股上市公司拟增持（表）
新浪证券 · 10-13
10月13日增减持汇总：新华制药等10股拟减持，当日暂无A股上市公司拟增持（表）
新华制药最新公告：公司董秘拟减持不超8.33万股股份
证券之星 · 10-13
新华制药最新公告：公司董秘拟减持不超8.33万股股份
新华制药提名刘伟民为董事候选人
同花顺 · 10-13
新华制药提名刘伟民为董事候选人
暂无数据
公司概况
公司名称：
山东新华制药股份有限公司
所属行业：
医药制造业
上市日期：
1997-08-06
主营业务：
山东新华制药股份有限公司的主营业务是开发、制造和销售化学原料药、制剂及化工产品。公司的主要产品是“新华牌”解热镇痛类药物、心脑血管类、抗感染类、中枢神经类。
发行价格：
3.45
{"stockData":{"symbol":"000756","market":"SZ","secType":"STK","nameCN":"新华制药","latestPrice":12.47,"timestamp":1794467022000,"preClose":12.58,"halted":0,"volume":9486801,"delay":0,"changeRate":-0.0087,"floatShares":499000000,"shares":697000000,"eps":0.3283,"marketStatus":"已收盘","change":-0.11,"latestTime":"11-12 15:00:00","open":12.59,"high":12.66,"low":12.46,"amount":119000000,"amplitude":0.0159,"askPrice":12.48,"askSize":248,"bidPrice":12.47,"bidSize":228,"shortable":0,"etf":0,"ttmEps":0.3283,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794533400000},"marketStatusCode":5,"adr":0,"adjPreClose":12.58,"symbolType":"stock","openAndCloseTimeList":[[1794447000000,1794454200000],[1794459600000,1794466800000]],"highLimit":13.84,"lowLimit":11.32,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":696683435,"isCdr":false,"pbRate":1.64,"roa":"--","peRate":37.983552,"roe":"3.67%","epsLYR":0.42,"committee":0.614842,"marketValue":8688000000,"turnoverRate":0.019,"status":1,"hkstockBrief":{"symbol":"00719","market":"HK","secType":"STK","nameCN":"山东新华制药股份","latestPrice":5.27,"timestamp":1794469412460,"preClose":5.355,"halted":0,"volume":292000,"delay":0,"premium":"-64.07"},"floatMarketCap":6221000000},"requestUrl":"/m/hq/s/000756/tweets","defaultTab":"tweets","newsList":[{"id":"2682726581","title":"股市必读：新华制药新发布《第十一届董事会2026年第三次临时会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2682726581","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682726581?lang=zh_cn&edition=full","pubTime":"2026-11-12 02:53","pubTimestamp":1794423191,"startTime":"0","endTime":"0","summary":"同日，公司召开第十一届董事会2026年第三次临时会议，选举刘伟民先生为第十一届董事会董事长；刘伟民先生现任公司党委书记、董事，未持有公司股份，与公司控股股东无关联关系，未受过监管部门处罚。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111200002572.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000756","BK0239","BK0164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682420973","title":"新华制药董事长贺同庆辞职；拜耳卒中新药在美国获批上市｜医药早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2682420973","media":"每日经济新闻","labels":["executive","productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682420973?lang=zh_cn&edition=full","pubTime":"2026-11-11 07:00","pubTimestamp":1794351612,"startTime":"0","endTime":"0","summary":"丨2026年11月11日星期三丨NO.1成大生物：拟斥资2500万元—5000万元回购股份，用于注销并减少注册资本11月10日，成大生物公告称，拟2500万元—5000万元回购公司股份，此次回购股份拟全部注销并相应减少公司注册资本，回购价格不超过30元/股（含）。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611113927764836.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611113927764836.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["09939","BK1515","IPOS","BK1574","159938","000756","BK1161","BK0239","BK0164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682310293","title":"股市必读：新华制药新发布《第十一届董事会2026年第三次临时会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2682310293","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682310293?lang=zh_cn&edition=full","pubTime":"2026-11-11 02:45","pubTimestamp":1794336316,"startTime":"0","endTime":"0","summary":"公司公告汇总第十一届董事会2026年第三次临时会议决议公告山东新华制药股份有限公司于2026年11月10日召开第十一届董事会2026年第三次临时会议，审议通过选举刘伟民先生为公司第十一届董事会董事长的议案；同时审议通过调整战略发展委员会、提名委员会、薪酬与考核委员会及审核委员会成员的议案。同日，公司召开第十一届董事会2026年第三次临时会议，选举刘伟民先生为公司第十一届董事会董事长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111100006107.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0164","000756","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682990563","title":"新华制药董事长由贺同庆变为刘伟民","url":"https://stock-news.laohu8.com/highlight/detail?id=2682990563","media":"北京商报","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682990563?lang=zh_cn&edition=full","pubTime":"2026-11-10 19:24","pubTimestamp":1794309897,"startTime":"0","endTime":"0","summary":"11月10日晚间，新华制药（000756）披露的董事长变动公告显示，公司当日收到贺同庆提交的书面辞职报告。贺同庆因工作变动原因申请辞去公司董事长、董事、董事会下辖各专门委员会委员及公司子公司所有职务，辞职后不在公司及子公司担任董事或高管职务。贺同庆原定任期至公司第十一届董事会届满之日止。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611103927463038.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611103927463038.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0164","000756","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682826985","title":"股市必读：新华制药新发布《关于获得酮咯酸氨丁三醇注射液药品注册证书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2682826985","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682826985?lang=zh_cn&edition=full","pubTime":"2026-11-09 03:32","pubTimestamp":1794166332,"startTime":"0","endTime":"0","summary":"公司公告汇总：新华制药获酮咯酸氨丁三醇注射液《药品注册证书》，批准文号国药准字H20266508，属化学药品3类，纳入《国家基本医疗保险、工伤保险和生育保险药品目录》乙类。公司公告汇总关于获得酮咯酸氨丁三醇注射液药品注册证书的公告山东新华制药股份有限公司近日收到国家药品监督管理局核准签发的酮咯酸氨丁三醇注射液《药品注册证书》，药品批准文号为国药准字H20266508，注册分类为化学药品3类。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110900000989.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000756","BK0239","BK0164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681141864","title":"新华制药最新公告：获得酮咯酸氨丁三醇注射液药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2681141864","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681141864?lang=zh_cn&edition=full","pubTime":"2026-11-06 21:44","pubTimestamp":1793972640,"startTime":"0","endTime":"0","summary":"新华制药(000756.SZ)公告称，公司收到国家药品监督管理局核准签发的酮咯酸氨丁三醇注射液《药品注册证书》。该药品适用于成人需要阿片水平镇痛的中重度急性疼痛的短期治疗，属于医保乙类品种。2025年中国公立医疗机构该药品销售额约2.3亿元。本次取得注册证书有利于丰富公司镇痛类产品系列，提高市场竞争力。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110600032908.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0164","BK0239","000756"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679252972","title":"新华制药（000756）2026年三季报简析：净利润同比下降23.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679252972","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679252972?lang=zh_cn&edition=full","pubTime":"2026-10-31 07:40","pubTimestamp":1793403627,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期新华制药发布2026年三季报。根据财报显示，新华制药净利润同比下降23.88%。截至本报告期末，公司营业总收入60.61亿元，同比下降10.38%，归母净利润1.95亿元，同比下降23.88%。按单季度数据看，第三季度营业总收入17.03亿元，同比下降19.8%，第三季度归母净利润4591.55万元，同比上升41.43%。去年的净利率为3.5%，算上全部成本后，公司产品或服务的附加值不高。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103100016613.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000756"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679418386","title":"图解新华制药三季报：第三季度单季净利润同比增长41.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679418386","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679418386?lang=zh_cn&edition=full","pubTime":"2026-10-29 01:45","pubTimestamp":1793209540,"startTime":"0","endTime":"0","summary":"证券之星消息，新华制药2026年三季报显示，前三季度公司主营收入60.61亿元，同比下降10.38%；归母净利润1.95亿元，同比下降23.88%；扣非净利润1.87亿元，同比下降21.82%；其中2026年第三季度，公司单季度主营收入17.03亿元，同比下降19.8%；单季度归母净利润4591.55万元，同比上升41.43%；单季度扣非净利润3958.3万元，同比上升40.38%；负债率36.6%，投资收益723.86万元，财务费用4430.6万元，毛利率18.69%。财报数据概要请见下图:本文数据来源于新华制药2026年三季报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900003351.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000756"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678745420","title":"新华制药董事会审议通过2026年第三季度报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2678745420","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678745420?lang=zh_cn&edition=full","pubTime":"2026-10-28 16:59","pubTimestamp":1793177940,"startTime":"0","endTime":"0","summary":"山东新华制药股份(00719.HK)第十一届董事会第十三次会议于2026年10月28日召开，8名董事全票审议通过公司2026年第三季度报告。会议同时审议通过关于提请董事会授权办理香港联交所联讯通平台 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261028/c681194510.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261028/c681194510.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["000756","BK0164","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677618874","title":"股市必读：新华制药新发布《关于尼莫地平片通过仿制药一致性评价的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2677618874","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677618874?lang=zh_cn&edition=full","pubTime":"2026-10-21 01:06","pubTimestamp":1792515972,"startTime":"0","endTime":"0","summary":"截至2026年10月20日收盘，新华制药报收于13.12元，下跌1.06%，换手率2.9%，成交量14.48万手，成交额1.9亿元。公司公告汇总：新华制药尼莫地平片通过仿制药质量和疗效一致性评价，系《国家基本医疗保险、工伤保险和生育保险药品目录》甲类品种，2025年中国公立医疗机构销售额约1.3亿元。尼莫地平片规格为30mg，属处方药，适用于预防和治疗动脉瘤性蛛网膜下腔出血后脑血管痉挛引起的缺血性神经损伤，以及老年性脑功能障碍。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100001397.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0164","BK0239","000756"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676293630","title":"新华制药（000756）10月19日主力资金净卖出2088.83万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2676293630","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676293630?lang=zh_cn&edition=full","pubTime":"2026-10-20 09:18","pubTimestamp":1792459099,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月19日收盘，新华制药报收于13.26元，下跌3.21%，换手率4.47%，成交量22.28万手，成交额2.96亿元。近5日资金流向一览见下表：新华制药融资融券信息显示，融资方面，当日融资买入2627.76万元，融资偿还2480.44万元，融资净买入147.32万元。融券方面，融券卖出200.0股，融券偿还100.0股，融券余量7.99万股，融券余额105.94万元。新华制药主营业务：开发、制造和销售化学原料药、制剂、医药中间体及其他产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102000006479.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000756","BK0164","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676502304","title":"新华制药：尼莫地平片通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2676502304","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676502304?lang=zh_cn&edition=full","pubTime":"2026-10-19 17:18","pubTimestamp":1792401480,"startTime":"0","endTime":"0","summary":"南财智讯10月19日电，新华制药公告，公司收到国家药品监督管理局核准签发的《药品补充申请批准通知书》，尼莫地平片通过仿制药质量和疗效一致性评价。该药品用于预防和治疗由于动脉瘤性蛛网膜下腔出血后脑血管痉挛引起的缺血性神经损伤，以及治疗老年性脑功能障碍。本品属于国家基本医疗保险、工伤保险和生育保险药品目录甲类品种。2025年中国公立医疗机构尼莫地平片销售额约为1.3亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610193899975182.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610193899975182.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0164","000756","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676578536","title":"股市必读：新华制药新发布《关于召开2026年第一次临时股东会的通知》","url":"https://stock-news.laohu8.com/highlight/detail?id=2676578536","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676578536?lang=zh_cn&edition=full","pubTime":"2026-10-19 01:04","pubTimestamp":1792343053,"startTime":"0","endTime":"0","summary":"公司公告汇总：新华制药将于2026年11月10日召开第一次临时股东大会，审议选举刘伟民为执行董事的议案，股权登记日为11月3日。公司公告汇总关于召开2026年第一次临时股东会的通知山东新华制药股份有限公司将于2026年11月10日召开2026年第一次临时股东会，现场会议时间为当日14时，网络投票时间为同日上午9:15至下午15:00。股权登记日为2026年11月3日，A股股东可参与投票。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900000337.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000756","BK0164","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675259185","title":"新华制药：关于召开2026年第一次临时股东会的通知","url":"https://stock-news.laohu8.com/highlight/detail?id=2675259185","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675259185?lang=zh_cn&edition=full","pubTime":"2026-10-16 19:23","pubTimestamp":1792149780,"startTime":"0","endTime":"0","summary":" 证券日报网讯 10月16日，新华制药发布公告称，公司将于2026年11月10日召开2026年第一次临时股东会。 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261016/c680791279.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261016/c680791279.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["000756","BK0164","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675785551","title":"新华制药（000756）10月15日主力资金净卖出172.58万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675785551","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675785551?lang=zh_cn&edition=full","pubTime":"2026-10-16 09:07","pubTimestamp":1792112843,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月15日收盘，新华制药报收于13.41元，上涨0.07%，换手率4.01%，成交量20.0万手，成交额2.7亿元。近5日资金流向一览见下表：新华制药融资融券信息显示，融资方面，当日融资买入2178.63万元，融资偿还2542.61万元，融资净偿还363.98万元。融券方面，融券卖出100.0股，融券偿还1400.0股，融券余量7.9万股，融券余额105.94万元。新华制药主营业务：开发、制造和销售化学原料药、制剂、医药中间体及其他产品。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600008739.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000756","BK0164","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675632992","title":"股市必读：新华制药新发布《关于高级管理人员减持股份的预披露公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2675632992","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675632992?lang=zh_cn&edition=full","pubTime":"2026-10-15 01:30","pubTimestamp":1791999032,"startTime":"0","endTime":"0","summary":"公司公告汇总关于高级管理人员减持股份的预披露公告山东新华制药股份有限公司董事会秘书曹长求先生计划在本公告发布之日起15个交易日后的3个月内，通过集中竞价方式减持公司股份不超过83,300股，占公司总股本的0.012%。本次减持基于个人资金需求，股份来源为股权激励授予。减持价格将根据市场价确定，减持期间为2026年11月5日至2027年2月4日。本次减持计划不会导致公司控制权变更，不影响公司治理结构和持续经营。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500001538.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000756","BK0164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675936859","title":"新华制药（000756）披露高级管理人员减持股份预披露公告，10月13日股价下跌1.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675936859","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675936859?lang=zh_cn&edition=full","pubTime":"2026-10-13 22:24","pubTimestamp":1791901461,"startTime":"0","endTime":"0","summary":"截至2026年10月13日收盘，新华制药报收于13.93元，较前一交易日下跌1.0%，最新总市值为97.05亿元。近日，新华制药发布《关于高级管理人员减持股份的预披露公告》。公告显示，公司董事会秘书曹长求先生计划在本公告发布之日起15个交易日后的3个月内，通过集中竞价方式减持公司股份不超过83,300股，占公司总股本的0.012%。截至公告日，曹长求先生持有公司股份333,200股，占总股本0.048%。减持价格将根据市场价确定，减持期间为2026年11月5日至2027年2月4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101300039961.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0164","000756"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675350732","title":"10月13日增减持汇总：新华制药等10股拟减持，当日暂无A股上市公司拟增持（表）","url":"https://stock-news.laohu8.com/highlight/detail?id=2675350732","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675350732?lang=zh_cn&edition=full","pubTime":"2026-10-13 22:14","pubTimestamp":1791900840,"startTime":"0","endTime":"0","summary":"10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与项飙现场对话！\n名额有限，手慢无。让我们共赴可持续之约！【点击报名】10月13日盘后，据不完全统计，包括神州细胞、云汉芯城、中胤时尚、康希通信、新致软件、美迪西、新华制药、惠发食品、华塑股份、天马科技在内的10家A股上市公司披露拟减持情况，当日暂无A股上市公司披露拟增持情况。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-10-13/doc-inivawnf8805426.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1610","159982","03130","000756","02843","82846","07233","82822","02846","399300","82843","03188","BK0239","BK0164","82823","83188","02823","BK1147","02827","83130","02822"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675333022","title":"新华制药最新公告：公司董秘拟减持不超8.33万股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2675333022","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675333022?lang=zh_cn&edition=full","pubTime":"2026-10-13 17:50","pubTimestamp":1791885038,"startTime":"0","endTime":"0","summary":"新华制药(000756.SZ)公告称，公司董事会秘书曹长求计划以集中竞价方式减持本公司股份不超过8.33万股，占公司总股本的0.012%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101300030031.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0164","BK0239","000756"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675381534","title":"新华制药提名刘伟民为董事候选人","url":"https://stock-news.laohu8.com/highlight/detail?id=2675381534","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675381534?lang=zh_cn&edition=full","pubTime":"2026-10-13 09:32","pubTimestamp":1791855120,"startTime":"0","endTime":"0","summary":"商报消息近日，新华制药(000756)发布公告，公司以书面传签方式召开第十一届董事会2026年第二次临时会议，审议通过《关于审议董事候选人的议案》，同意刘伟民为该公司第十一届董事会非独立执 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261013/c680619550.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261013/c680619550.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BK0164","BK0239","000756"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1794487706995,"stockEarnings":[{"period":"1week","weight":-0.0079},{"period":"1month","weight":-0.1059},{"period":"3month","weight":-0.1033},{"period":"6month","weight":-0.1098},{"period":"1year","weight":-0.2499},{"period":"ytd","weight":-0.1745}],"compareEarnings":[{"period":"1week","weight":-0.0015},{"period":"1month","weight":-0.0307},{"period":"3month","weight":-0.0627},{"period":"6month","weight":-0.11},{"period":"1year","weight":-0.0805},{"period":"ytd","weight":-0.0726}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"山东新华制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"0人","perCapita":"--","listingDate":"1997-08-06","address":"山东省淄博市张店区高新区鲁泰大道1号","registeredCapital":"69668万元","survey":" 山东新华制药股份有限公司的主营业务是开发、制造和销售化学原料药、制剂及化工产品。公司的主要产品是“新华牌”解热镇痛类药物、心脑血管类、抗感染类、中枢神经类。","listedPrice":3.45},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"新华制药(000756)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供新华制药(000756)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"新华制药,000756,新华制药股票,新华制药股票老虎,新华制药股票老虎国际,新华制药行情,新华制药股票行情,新华制药股价,新华制药股市,新华制药股票价格,新华制药股票交易,新华制药股票购买,新华制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"新华制药(000756)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供新华制药(000756)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}